The limited effect of nasal interferon induced by rhinovirus and a topical chemical inducer on the course of infection.
D000281:Administration, Intranasal; D000914:Antibodies, Viral / Q000032:analysis; D001681:Biological Assay; D002277:Carcinoma; D002460:Cell Line; D002986:Clinical Trials as Topic; D003139:Common Cold / Q000188:drug therapy* / Q000276:immunology; D003588:Cytopathogenic Effect, Viral; D005122:Exudates and Transudates / Q000032:analysis; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D007372:Interferons / Q000032:analysis / Q000494:pharmacology*; D007822:Laryngeal Neoplasms; D008168:Lung; D009297:Nasal Mucosa; D009305:Nasopharynx / Q000382:microbiology; D010919:Placebos; D012229:Rhinovirus / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D013997:Time Factors; D014721:Vesicular stomatitis Indiana virus; D014776:Virus Cultivation
D000914:Antibodies, Viral; D007369:Interferon Inducers; D010919:Placebos; D007372:Interferons